As shown in Figure 6A, we observed that the expressions of PINK1 and Parkin were elevated in the AD model compared to the control cells according to Western blot analysis, while M2-EXOs reduced the expression of PINK1 and Parkin in a dose-dependent manner. Here, PRKN is linked to Alzheimer disease.